Jeanne Poole is a Cardiology physician affiliated with University of Washington. OpenAlex indexes 12 publications with 487 citations (h-index 3); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1959 NE Pacific St
Seattle, WA 981950001
Telephone
206-598-4300Registry record last updated 8 Apr 2011.
Clinical trials
- ASSURE WCD Clinical Evaluation - Post Approval Study (ACE-PAS)
Sponsor: Kestra Medical Technologies, Inc.
- ASSURE WCD Clinical Evaluation - Detection and Safety Study
Sponsor: Kestra Medical Technologies, Inc.
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Boston Scientific CorporationProgram year202510 payments$22,613openpaymentsdata.cms.gov ↗
- BIOTRONIK INC.Program year20258 payments
- Biosense Webster, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
67.6%Beta blocker29%Metoprolol Succinate73%Sotalol16%Metoprolol Tartrate11%Part D<11 patientsAntiarrhythmic25.5%Amiodarone Hcl44%Dofetilide25%Flecainide Acetate21%Mexiletine Hcl10%Part D<11 patients+ 4 more classes in this area
Blood & clotting
29.9%Factor Xa inhibitor29.9%Eliquis89%Savaysa12%Part D<11 patientsNervous system
2.5%Benzodiazepine2.5%Alprazolam100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Cost-Effectiveness of an Antibacterial Envelope for Cardiac Implantable Electronic Device Infection Prevention in the US Healthcare System From the WRAP-IT Trial
Circulation Arrhythmia and Electrophysiology
2020 - Clinical Presentation, Timing, and Microbiology of CIED Infections
JACC. Clinical electrophysiology
2020
Similar KOLs
Other experts from the same institution or the same specialty.
Neal Futran, MD, DMD
University of Washington
Elizabeth Swisher
University of Washington
David Tirschwell
University of Washington
Elaine Peskind, MD
University of Washington
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”